Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-grade Anal Intraepithelial Neoplasia × Cidofovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Squamous Intraepithelial Lesions 2 Precancerous Conditions 2 Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Sarcoma, Kaposi 1 Sarcoma 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Papillomavirus Infections 1 Papilloma 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1

Interventions

green tea extract polyphenone E 1 Ointments 1 Electrocoagulation 1 Cidofovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04055142 2024-07-10

TreatAIN

Hospital Universitari Vall d'Hebron Research Institute

Phase 3 Completed

High-grade Anal Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡